In this connection, naphthazarin and its derivative S64 were shown to radiosensitize breast cancer MCF-7 cells [171] or inhibit the DNA-binding activity of HSF1 and deplete GSH in hypoxic colon cancer cells [172]; these findings suggest a potential use of both agents for targeting hypoxic tumors. This evidence concerns the gene HSF1 and breast carcinoma.